Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:OMICNASDAQ:RPIDNASDAQ:TLIS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeOMICSingular Genomics Systems$20.01$20.01$5.34▼$23.41$50.83M1.8344,530 shsN/ARPIDRapid Micro Biosystems$3.26-8.2%$2.57$0.58▼$4.04$142.89M1.13189,832 shs107,888 shsTLISTalis Biomedical$1.50$1.59$1.04▼$9.53$2.73M1.332,902 shsN/AFree Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceOMICSingular Genomics Systems0.00%0.00%0.00%0.00%+75.07%RPIDRapid Micro Biosystems+8.56%+11.29%+57.78%+31.00%+332.93%TLISTalis Biomedical0.00%+6.38%-6.25%-14.29%-83.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationOMICSingular Genomics SystemsN/AN/AN/AN/AN/AN/AN/AN/ARPIDRapid Micro Biosystems1.5276 of 5 stars2.03.00.00.02.72.50.6TLISTalis BiomedicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceOMICSingular Genomics Systems 2.00Hold$6.50-67.52% DownsideRPIDRapid Micro Biosystems 4.00Strong Buy$8.00145.40% UpsideTLISTalis Biomedical 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookOMICSingular Genomics Systems$2.91M17.47N/AN/A$73.25 per share0.27RPIDRapid Micro Biosystems$29.65M4.82N/AN/A$2.78 per share1.17TLISTalis Biomedical$300K9.12N/AN/A$37.95 per share0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateOMICSingular Genomics Systems-$94.82M-$35.11N/A∞N/A-3,237.89%-57.87%-37.90%8/12/2025 (Estimated)RPIDRapid Micro Biosystems-$52.47M-$1.03N/AN/AN/A-184.93%-48.05%-39.18%8/1/2025 (Estimated)TLISTalis Biomedical-$62.01M-$28.02N/A∞N/AN/A-79.74%-57.16%N/ALatest OMIC, TLIS, and RPID EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 million2/28/2025Q4 2024RPIDRapid Micro Biosystems-$0.22-$0.22N/A-$0.22$8.20 million$8.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthOMICSingular Genomics SystemsN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ATLISTalis BiomedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioOMICSingular Genomics Systems0.047.376.67RPIDRapid Micro BiosystemsN/A5.524.19TLISTalis BiomedicalN/A7.767.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipOMICSingular Genomics Systems65.80%RPIDRapid Micro Biosystems52.60%TLISTalis Biomedical43.77%Insider OwnershipCompanyInsider OwnershipOMICSingular Genomics Systems22.20%RPIDRapid Micro Biosystems29.96%TLISTalis Biomedical46.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableOMICSingular Genomics Systems2202.54 million1.97 millionNo DataRPIDRapid Micro Biosystems20043.83 million29.95 millionNot OptionableTLISTalis Biomedical2601.82 million984,000No DataOMIC, TLIS, and RPID HeadlinesRecent News About These CompaniesBaker Bros. Advisors LP's Strategic Acquisition in Talis Biomedical CorpOctober 11, 2024 | finance.yahoo.comTalis Biomedical Agrees to Settle Investor Suit for $33 MillionOctober 3, 2024 | news.bloomberglaw.comTalis Biomedical Corp Ordinary SharesSeptember 17, 2024 | morningstar.comInsider Buying: Talis Biomedical Co. (NASDAQ:TLIS) Major Shareholder Buys 13,167 Shares of StockAugust 29, 2024 | insidertrades.comTalis Biomedical Shares Fall on Bankruptcy Filing, Delisting NoticeAugust 24, 2024 | marketwatch.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q2 2024August 20, 2024 | investorplace.comTalis Biomedical Shares Tumble Premarket as Company Mulls BankruptcyAugust 7, 2024 | marketwatch.comWhy Talis Biomedical (TLIS) Stock Is Getting Obliterated TodayAugust 7, 2024 | benzinga.comWhy Is Talis Biomedical (TLIS) Stock Down 52% Today?August 7, 2024 | investorplace.com(TLIS) Trading ReportJuly 25, 2024 | news.stocktradersdaily.comTalis Biomedical Corp (TLIS)May 10, 2024 | investing.comTLIS Stock Earnings: Talis Biomedical Reported Results for Q1 2024May 8, 2024 | investorplace.comBragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and ...April 27, 2024 | eagletribune.comTalis Biomedical Corporation (TLIS)March 31, 2024 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Talis Biomedical CorporationFebruary 16, 2024 | markets.businessinsider.comTLIS Feb 2024 2.500 putFebruary 15, 2024 | finance.yahoo.comPeninsula diagnostics company to close Redwood City labs and offices, pursue 'strategic alternatives'November 14, 2023 | bizjournals.comTalis Biomedical Corporation: Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNovember 14, 2023 | finanznachrichten.deLICY, BTAI and HROW among mid-day moversNovember 14, 2023 | msn.comTalis reviewing strategic alternatives, stock rallies 35%November 14, 2023 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesOklo Reaches Critical Mass, Atomic Upside Still AvailableBy Thomas Hughes | May 14, 2025View Oklo Reaches Critical Mass, Atomic Upside Still Available3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to PassBy Jea Yu | April 29, 2025View 3M Stock: 4 Compelling Reasons to Buy, 1 Big Reason to PassGold’s Record Run in 2025: Here Are 3 Ways to Ride the SurgeBy Ryan Hasson | May 7, 2025View Gold’s Record Run in 2025: Here Are 3 Ways to Ride the SurgeMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2By Leo Miller | May 2, 2025View Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Recession Prep: Consumer Staples are BackBy Jeffrey Neal Johnson | May 5, 2025View Recession Prep: Consumer Staples are BackOMIC, TLIS, and RPID Company DescriptionsSingular Genomics Systems NASDAQ:OMIC$20.01 0.00 (0.00%) As of 02/21/2025Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables for applications comprising single cell gene expression and proteomics, in situ RNA sequencing, and spatial RNA and proteomics applications for tissue. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.Rapid Micro Biosystems NASDAQ:RPID$3.26 -0.29 (-8.17%) Closing price 04:00 PM EasternExtended Trading$3.52 +0.27 (+8.13%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.Talis Biomedical NASDAQ:TLIS$1.50 0.00 (0.00%) As of 05/27/2025Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Microsoft's Outlook Brightens as Analysts Boost Bullish Ratings ThredUp Stock Reverses on AI Buzz, Eyes Double-Digit Gains Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
